Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
复制标题
DOI:
10.1186/2051-5960-2-53
复制
发表时间:
2014-05-09
影响因子:
7.1
通讯作者:
Morgan BP
中科院分区:
文献类型:
--
作者:
Ingram G;Loveless S;Howell OW;Hakobyan S;Dancey B;Harris CL;Robertson NP;Neal JW;Morgan BP
Inflammation and complement activation are firmly implicated in the pathology of multiple sclerosis; however, the extent and nature of their involvement in specific pathological processes such as axonal damage, myelin loss and disease progression remains uncertain. This study aims to bring clarity to these questions. We describe a detailed immunohistochemical study to localise a strategically selected set of complement proteins, activation products and regulators in brain and spinal cord tissue of 17 patients with progressive multiple sclerosis and 16 control donors, including 9 with central nervous system disease. Active, chronic active and chronic inactive multiple sclerosis plaques (35 in total) and non-plaque areas were examined. Multiple sclerosis plaques were consistently positive for complement proteins (C3, factor B, C1q), activation products (C3b, iC3b, C4d, terminal complement complex) and regulators (factor H, C1-inhibitor, clusterin), suggesting continuing local complement synthesis, activation and regulation despite the absence of other evidence of ongoing inflammation. Complement staining was most apparent in plaque and peri-plaque but also present in normal appearing white matter and cortical areas to a greater extent than in control tissue. C1q staining was present in all plaques suggesting a dominant role for the classical pathway. Cellular staining for complement components was largely restricted to reactive astrocytes, often adjacent to clusters of microglia in close apposition to complement opsonised myelin and damaged axons. The findings demonstrate the ubiquity of complement involvement in multiple sclerosis, suggest a pathogenic role for complement contributing to cell, axon and myelin damage and make the case for targeting complement for multiple sclerosis monitoring and therapy. The online version of this article (doi:10.1186/2051-5960-2-53) contains supplementary material, which is available to authorized users.
登录
查看更多内容
DOI:
10.1177/1352458512438238
发表时间:
2012-10
期刊:
Multiple sclerosis (Houndmills, Basingstoke, England)
影响因子:
--
作者:
Ingram G;Hakobyan S;Hirst CL;Harris CL;Loveless S;Mitchell JP;Pickersgill TP;Robertson NP;Morgan BP
通讯作者:
Morgan BP
影响因子:
2.9
作者:
LUMSDEN, CE
通讯作者:
LUMSDEN, CE
影响因子:
4.4
作者:
Kira, Jun-ichi
通讯作者:
Kira, Jun-ichi
影响因子:
11.2
作者:
Breij, Esther C. W.;Brink, Bianca P.;Boe, Lars
通讯作者:
Boe, Lars
影响因子:
15.9
作者:
Qin, YF;Duquette, P;Antel, J
通讯作者:
Antel, J